SCHEMBL26979409

SCHEMBL26979409

CC(=O)Nc1ccccc1C(=O)Nc1ccc([N+](=O)[O-])cc1Cl

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 8/20 0.63
MAPT P10636 7/20 0.60
KMT2A Q03164 4/20 0.60
LMNA P02545 4/20 0.60
MEN1 O00255 3/20 0.60
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
MAPK1 P28482 2/20 0.60
ALDH1A1 P00352 2/20 0.60
HTT P42858 2/20 0.60
AURKA O14965 1/20 0.60
PDPK1 O15530 1/20 0.60
JAK2 O60674 1/20 0.60
GMNN O75496 1/20 0.60
EGFR P00533 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
LYN P07948 1/20 0.60
CHRM2 P08172 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8930598 0.87 MAPT (0.63) MAPTKMT2ALMNAMEN1NPC1
SCHEMBL24460413 0.86 RORC (0.65) RORCMAPTKMT2ALMNAMEN1
SCHEMBL4264455 0.84 KCNMA1 (0.78) RORCMAPTKMT2ALMNAMEN1
SCHEMBL29936061 0.84 KCNMA1 (0.78) RORCMAPTKMT2ALMNAMEN1
SCHEMBL22007921 0.84 MEN1 (0.64) RORCMAPTKMT2ALMNAMEN1
SCHEMBL11826307 0.82 RORC (0.56) RORCMAPTKMT2ALMNAMEN1
SCHEMBL6816172 0.82 MAPT (0.71) RORCMAPTKMT2ALMNAMEN1
SCHEMBL28544222 0.82 MAPT (0.66) RORCMAPTKMT2ALMNAMEN1
SCHEMBL25394310 0.82 MAPT (0.71) MAPTKMT2ALMNAMEN1NPC1
SCHEMBL8054228 0.81 SMN1; SMN2 (0.67) RORCMAPTKMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2024-01-04 US claimed
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION 2024-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002332-A1 Small Molecule Inhibitors of SARS-CoV-2 Infections ACE2, ACE, TMPRSS2 RORC 961/4885MAPT 2694/4885KMT2A 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.